A Phase I Study to Evaluate the Safety, Tolerability, Pharmacology, and Preliminary Efficacy of AT-0174 in Subjects with Advanced Solid Malignancies
ACTRN 12623000956606 Brief Summary This study will be conducted in two parts…
Read more arrow_forward